论文信息 - FDA Approval Summary: Nivolumab plus ipilimumab for the treatment of patients with hepatocellular carcinoma previously treated with sorafenib. - 字舞流文

FDA Approval Summary: Nivolumab plus ipilimumab for the treatment of patients with hepatocellular carcinoma previously treated with sorafenib.

L. Fashoyin-Aje | Martha Donoghue | K. Goldberg | R. Pazdur | Mengdie Yuan | M. Theoret | Lorraine C Pelosof | P. Schotland | May Tun Saung | S. Lemery | Lisa Rodriguez | M. Chuk | S. Casak | Lorraine C. Pelosof | G. Davis | Kirsten B. Goldberg | Lisa R Rodriguez